Literature DB >> 3429369

The inoculum effect with gram-negative bacteria in vitro and in vivo.

P G Davey1, M Barza.   

Abstract

The in-vitro MICs and MBCs of ciprofloxacin, cefoperazone, ceftazidime, ceftriaxone, gentamicin and imipenem were measured for five strains each of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa with standard and high inocula. The MBC was raised more than the MIC at the higher inoculum for all the drugs except ciprofloxacin. However, the MBC of imipenem against P. aeruginosa was increased relatively little at the higher inoculum in contrast to the findings with other beta-lactam drugs. In a rabbit model of endophthalmitis both cefoperazone and imipenem were markedly more bactericidal against a high inoculum of K. pneumoniae than would have been predicted from the results of in-vitro time kill curve studies. We conclude that the therapeutic relevance of the inoculum effect remains to be proved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3429369     DOI: 10.1093/jac/20.5.639

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments.

Authors:  Bruce R Levin; Klas I Udekwu
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

2.  BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain.

Authors:  Franz Hagn; Christian Klein; Oliver Demmer; Natasha Marchenko; Angelina Vaseva; Ute M Moll; Horst Kessler
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

3.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

5.  Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.

Authors:  D Salmon; P Deloron; C Gaudin; K Malhotra; J Lebras; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

7.  Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.

Authors:  Jürgen B Bulitta; Neang S Ly; Jenny C Yang; Alan Forrest; William J Jusko; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

8.  Inoculum effect of antimicrobial peptides.

Authors:  Maria Rosa Loffredo; Filippo Savini; Sara Bobone; Bruno Casciaro; Henrik Franzyk; Maria Luisa Mangoni; Lorenzo Stella
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

9.  Inoculum effect of Enterobacterales co-expressing OXA-48 and CTX-M on the susceptibility to ceftazidime/avibactam and meropenem.

Authors:  A Mizrahi; L Chat; M Danjean; C Mory; J C Nguyen Van; G Péan de Ponfilly; F Caméléna; A Le Monnier; B Bercot; A Birgy; H Jacquier; B Pilmis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-03-23       Impact factor: 3.267

10.  Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocols.

Authors:  Klas I Udekwu; Bruce R Levin
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.